Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)
1513 results found
2023 ∙ Zhang, H. Q. Cao, B. Z. Cao, Q. T. Hun, M. Cao, L. Zhao, M. Y.
An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Bachour, Y.
An update and overview of the literature on late inflammatory reactions (LIRs) in soft tissue fillers after SARS-CoV-2 infection and vaccination
All age groups COVID-19 Safety
Rating:
Critically low
2023 ∙ Thammathiwat, T. Banjongjit, A. Iampenkhae, K. Townamchai, N. Kanjanabuch, T.
ANCA Associated Glomerulonephritis Following SARS-CoV-2 Vaccination: A Case Series and Systematic Review
Adults Older adults COVID-19 Safety
Rating:
Critically low
2023 ∙ Dimitroglou, Margarita Sokou, Rozeta Iacovidou, Nicoletta Pouliakis, Abraham Kafalidis, Georgios Boutsikou, Theodora Iliodromiti, Zoi
Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination-Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review
Pregnant women COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Dimitroglou, M. Sokou, R. Iacovidou, N. Pouliakis, A. Kafalidis, G. Boutsikou, T. Iliodromiti, Z.
Anti-SARS-CoV-2 Immunoglobulins in Human Milk after Coronavirus Disease or Vaccination—Time Frame and Duration of Detection in Human Milk and Factors That Affect Their Titers: A Systematic Review
All age groups Pregnant women COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Roslan, M. Nisfu, F. R. M. Arzmi, M. H. Wahab, R. A. Zainuddin, N.
Antibody Response against Severe Acute Respiratory Syndrome Coronavirus 2 Messenger Ribonucleic Acid Vaccines in Infected Individuals: A Systematic Review
Healthcare workers COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Domado, A. M. Adaza, H. J. F. Beltran, Apnc Buenviaje, L. M. Co, C. D. Combalicer, L. R. Corona, S. M. A. Cruz, J. B. F. Dinjotian, Macg Esperanzate, E. M. S. Luna, S. R. G. Pascua, E. J. R. Vicencio, R. R. T. Reyes, S. N.
Antibody titers of individuals vaccinated for COVID-19: A systematic review
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Hoang, T. N. A. Quach, H. L. Hoang, V. N. Tran, V. T. Pham, Q. T. Vogt, F.
Assessing the robustness of COVID-19 vaccine efficacy trials: systematic review and meta-analysis, January 2023
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2023 ∙ Watanabe, A. Kani, R. Iwagami, M. Takagi, H. Yasuhara, J. Kuno, T.
Assessment of Efficacy and Safety of mRNA COVID-19 Vaccines in Children Aged 5 to 11 Years: A Systematic Review and Meta-analysis
Children Adolescents COVID-19 Efficacy/effectiveness Safety
Rating:
Critically low
2023 ∙ Jukic, I. Heffernan, A. Schelling, A. F. Kokic Males, V. Savicevic, N. J. Kovacic, V.
Association between COVID-19 Infection or Vaccination Outcomes and Methylenetetrahydrofolate Reductase Gene Polymorphism: A Systematic Review of the Literature
Adults COVID-19 Safety
Rating:
Critically low
Loading...